Debt-to-equity in % of Anixa Biosciences Inc from Q1 2015 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Anixa Biosciences Inc quarterly Debt-to-equity history and change rate from Q1 2015 to Q2 2025.
  • Anixa Biosciences Inc Debt-to-equity for the quarter ending 31 Jul 2025 was 13.1 %, a 55.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 13.1 +4.67 +55.7% 31 Jul 2025
Q1 2025 12.1 +4.3 +54.9% 30 Apr 2025
Q4 2024 10.7 +3.17 +42.3% 31 Jan 2025
Q3 2024 9.4 +2.49 +36% 31 Oct 2024
Q2 2024 8.38 +1.71 +25.6% 31 Jul 2024
Q1 2024 7.84 +1.81 +30% 30 Apr 2024
Q4 2023 7.5 +1.99 +36.1% 31 Jan 2024
Q3 2023 6.92 +1.2 +21% 31 Oct 2023
Q2 2023 6.67 +1.77 +36.1% 31 Jul 2023
Q1 2023 6.02 30 Apr 2023
Q4 2022 5.51 31 Jan 2023
Q3 2022 5.72 31 Oct 2022
Q2 2022 4.9 31 Jul 2022
Q3 2020 16.7 31 Oct 2020
Q2 2020 20.2 31 Jul 2020
Q3 2017 118 -96.2 -45% 31 Oct 2017
Q2 2017 308 +165 +114% 31 Jul 2017
Q1 2017 846 +739 +696% 30 Apr 2017
Q4 2016 1.52K +1.43K +1746% 31 Jan 2017
Q3 2016 214 +147 +217% 31 Oct 2016
Q2 2016 144 +70.7 +96.5% 31 Jul 2016
Q1 2016 106 -35.3 -24.9% 30 Apr 2016
Q4 2015 82.1 31 Jan 2016
Q3 2015 67.4 31 Oct 2015
Q2 2015 73.2 31 Jul 2015
Q1 2015 141 30 Apr 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.